Analysis of the Allergan Inc.

Publication Date	August 2007
Publisher	Aruvian Research
Product Type	Report
Pages	60
ISBN Number	not applicable
Product Code	ARU00447

Price

£335.00
approximately: $498 | €394

PDF

PRINT £1,075 ($1,596 | €1,265)

CD-ROM £675 ($1,002 | €794)

Order above formats by FAX

Summary

Allergan, Inc. is a global healthcare company that develops and commercializes specialty pharmaceutical products for the ophthalmic, neurological, dermatological and other specialty markets. The company operates in specialty pharmaceutical research, targeting products and technologies related to specific disease areas such as glaucoma, retinal disease, dry eye, psoriasis, acne and movement disorders.

Allergan also focuses on research and development efforts on new therapeutic areas, including gastroenterology, neuropathic pain and genitourinary diseases.

Aruvian Research presents Analysis of Allergan Inc. A complete and comprehensive analysis of Dow, the world's leading insurance company, includes an overview of the pharmaceutical industry in the United States, a PEST Framework Analysis of the US Pharmaceutical Industry, and then moves on to analyzing the company itself.

Company analysis from Aruvian includes a history of Allergan Inc, a business segment analysis of the segments Allergan operates through, a look at the organization structure of the company, a geographical operating segments analysis, an analysis of the company's major competitors namely Alcon, Bausch & Lomb, Johnson & Johnson, and Pfizer.

A financial analysis of Allergan Inc is presented in the report which includes a ratio analysis, basic profit and loss analysis, presentation of the company balance sheet, and much more.

A SWOT Framework Analysis of Allergan completes this in-depth company analysis.

Content

A. Executive Summary
B. Looking at the Industry
- B.1 Industry Definition
- B.2 Brief Profile of the US Pharmaceutical Industry
- B.3 Impacts on the Industry
- B.4 Challenges Facing the Industry
- B.5 Future Perspective
C. US Pharmaceutical Industry - PEST Framework Analysis
- C.1 Political Aspects
- C.2 Economic Aspects
- C.3 Social Aspects
- C.4 Technological Aspects
D. Looking at Allergan Inc
- D.1 Company Profile
- D.2 History of the Company
- D.3 Ownership Pattern in the Company
- D.4 Corporate Hierarchy
- D.5 Organizational Divisions
- D.6 Profiling the Key Executives
- D.7 Products & Services
- D.8 Corporate Strategies
- D.9 Recently in the News
E. Looking at Business
- E.1 Business Segments
- E.2 Geographical Segments
- E.3 Mergers & Acquisitions Profile
- E.4 Company Subsidiaries
F. Allergan Inc: SWOT Framework Analysis
- F.1 Strengths to Build Upon
- F.2 Weaknesses to Overcome
- F.3 Opportunities to Exploit
- F.4 Threats to Overcome
G. Profiling the Competition
- G.1 Alcon
- G.2 Bausch & Lomb
- G.3 Johnson & Johnson
- G.4 Pfizer
H. Allergan Inc - Financial Analysis
- H.1 Current Financials
- H.2 Balance Sheet
- H.3 Profit & Loss Statement
- H.4 Ratio Analysis
I. AIG: Future Perspective
J. Appendix
K. Glossary of Terms